10.1080/14728214.2019.1591370 67 MilenkovicU.IlgM
The label change that weight-loss drug companies are cashing in on While a GLP-1 friendly label may seem arbitrary, some medical experts say it may make people pay closer attention to what theyre eating Bookmark CommentsGo to comments Food manufacturers are trying to cash in on the popularity of weight-loss medications such as Ozempic and Mounjaro, with a growing number of easy, grab-and-go meals and snacks being sold as GLP-1 friendly. These labels might highlight that a meal or snack is higher in protein and fiber, or simply a smaller portion size than other options although consumers should be skeptical of any health benefits, experts say
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH) that acts as a selective agonist of the growth-hormone secretagogue receptor (GHS-R1a, the ghrelin receptor)
This enhanced efficacy in obesity suggests the compound may normalize dysfunctional hypothalamic signaling present in obese states
Reina will offer lifestyle guidance, including dietary recommendations and exercise plans, to complement the effects of semaglutide
The role of hydrogen peroxide in redox-dependent signaling: Homeostatic and pathological responses in mammalian cells
